Post-Transplant Right Ventricular Failure

  • Marshall T. Bell
  • David A. FullertonEmail author
Part of the Difficult Decisions in Surgery: An Evidence-Based Approach book series (DDSURGERY)


The right ventricle is particularly vulnerable to acute failure during cardiac transplantation, and post-transplant right ventricular failure is associated with significant perioperative morbidity and mortality. But provided that early recognition and aggressive treatment is initiated, such right ventricular failure has a relatively high rate of recovery. Such treatment requires multimodal therapy including optimization of preload, ionotropic support, afterload reduction and if necessary, mechanical circulatory support.


Cardiac surgery Transplantation Right ventricular dysfunction/failure 


  1. 1.
    Lund LH, Edwards LB, Kucheryavaya AY, Benden C, Goldfarb S, Levvey BJ, et al. Transplantation: thirty-second official adult heart transplantation report – 2015; focus theme: early graft failure. J Heart Lung Transplant. 2015;34(10):1244–54.CrossRefGoogle Scholar
  2. 2.
    Stobierska-Dzierzek B, Awad H, Michler RE. The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol. 2001;38(4):923–31.PubMedCrossRefGoogle Scholar
  3. 3.
    Squiers JJ, Saracino G, Chamogeorgakis T, MacHannaford JC, Rafael AE, Gonzalez-Stawinski GV, et al. Application of the international society for heart and lung transplantation (ISHLT) criteria for primary graft dysfunction after cardiac transplantation: outcomes from a high-volume center. Eur J Cardiothorac Surg. 2017;51(2):263–70.PubMedGoogle Scholar
  4. 4.
    Mehra MR, Canter CE, Hannan MM, Semigran MJ, Uber PA, Baran DA, et al. The 2016 international society for heart lung transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant. 2016;35(1):1–23.PubMedCrossRefGoogle Scholar
  5. 5.
    Costard-Jäckle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol. 1992;19(1):48–54.PubMedCrossRefGoogle Scholar
  6. 6.
    Yeoh TK, Frist WH, Lagerstrom C, Kasper EK, Groves J, Merrill W. Relationship of cardiac allograft size and pulmonary vascular resistance to long-term cardiopulmonary function. J Heart Lung Transplant. 1992;11(6):1168–76.PubMedGoogle Scholar
  7. 7.
    Kwon MH, Wong S, Kittleson M, Ardehali A, Laks H, Shemin RJ, et al. Selecting oversized donor cardiac allografts for patients with pulmonary hypertension may be unnecessary. Transplant Proc. 2014;46(5):1497–50.PubMedCrossRefGoogle Scholar
  8. 8.
    Ardehali A, Hughes K, Sadeghi A, Esmailian F, Marelli D, Moriguchi J, et al. Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Transplantation. 2001;72(4):638–41.PubMedCrossRefGoogle Scholar
  9. 9.
    Solina AR, Ginsberg SH, Papp D, Grubb WR, Scholz PM, Pantin EJ, et al. Dose response to nitric oxide in adult cardiac surgery patients. J Clin Anesth. 2001;13(4):281–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Haraldsson A, Kieler-Jensen N, Ricksten SE. Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study. J Cardiothorac Vasc Anesth. 1996;10(7):864–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Theodoraki K, Tsiapras D, Tsourelis L, Zarkalis D, Sfirakis P, Kapetanakis E, et al. Inhaled iloprost in eight heart transplant recipients presenting with post-bypass acute right ventricular dysfunction. Acta Anaesthesiol Scand. 2006;50(10):1213–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Khan TA, Schnickel G, Ross D, Bastani S, Laks H, Esmailian F, Marelli D, et al. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients. J Thorac Cardiovasc Surg. 2009;138(6):1417–24.PubMedCrossRefGoogle Scholar
  13. 13.
    De Santo LS, Mastroianni C, Romano G, Amarelli C, Marra C, Maiello C, et al. Role of sildenafil in acute posttransplant right ventricular dysfunction: successful experience in 13 consecutive patients. Transplant Proc. 2008;40(6):2015–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Singh RK, Richmond ME, Zuckerman WA, Lee TM, Giblin TB, Rodriguez R, et al. The use of oral sildenafil for management of right ventricular dysfunction after pediatric heart transplantation. Am J Transplant. 2014;14(2):453–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Arafa OE, Geiran OR, Andersen K, Fosse E, Simonsen S, Svennevig JL. Intraaortic balloon pumping for predominantly right ventricular failure after heart transplantation. Ann Thorac Surg. 2000;70(5):1587–93.PubMedCrossRefGoogle Scholar
  16. 16.
    Chen JM, Levin HR, Rose EA, Addonizio LJ, Landry DW, Sistino JJ, et al. Experience with right ventricular assist devices for perioperative right-sided circulatory failure. Ann Thorac Surg. 1996;61(1):305–10.PubMedCrossRefGoogle Scholar
  17. 17.
    Sugiki H, Nakashima K, Vermes E, Loisance D, Kirsch M. Temporary right ventricular support with Impella Recover RD axial flow pump. Asian Cardiovasc Thorac Ann. 2009;17(4):395–400.PubMedCrossRefGoogle Scholar
  18. 18.
    Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus PT, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J. 2015;36(33):2246–56.PubMedCrossRefGoogle Scholar
  19. 19.
    Tchantchaleishvili V, Wood KL, Carlson LA, Barrus B, Swartz MF, Vidula H, et al. Temporary mechanical circulatory support after orthotopic heart transplantation: a single-centre experience. Interact Cardiovasc Thorac Surg. 2017;25(1):41–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Taghavi S, Zuckermann A, Ankersmit J, Wieselthaler G, Rajek A, Laufer G, et al. Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation. Ann Thorac Surg. 2004;78(5):1644–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Bergenfeldt H, Stehlik J, Höglund P, Andersson B, Nilsson J. Donor-recipient size matching and mortality in heart transplantation: influence of body mass index and gender. J Heart Lung Transplant. 2017;36(9):940–7.PubMedCrossRefGoogle Scholar
  22. 22.
    McGinn K, Reichert MA. Comparison of inhaled nitric oxide versus inhaled epoprostenol for acute pulmonary hypertension following cardiac surgery. Ann Pharmacother. 2016;50(1):22–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Sabato LA, Salerno DM, Moretz JD, Jennings DL. Inhaled pulmonary vasodilator therapy for management of right-ventricular dysfunction after left ventricular assist device placement and cardiac transplantation. Pharmacotherapy. 2017;37:944–55.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.The Division of Cardiothoracic SurgeryUniversity of Colorado School of MedicineAuroraUSA

Personalised recommendations